Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005391591 | SCV006050195 | uncertain significance | not specified | 2025-01-25 | criteria provided, single submitter | clinical testing | The c.35G>A (p.R12Q) alteration is located in exon 1 (coding exon 1) of the PDHA2 gene. This alteration results from a G to A substitution at nucleotide position 35, causing the arginine (R) at amino acid position 12 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |